Results 161 to 170 of about 2,548 (213)

APPLICATION OF ORAL IMMUNOTHERAPY (OIT) CLINICAL TRIAL ENDPOINTS TO A REAL-WORLD SETTING

Annals of Allergy, Asthma & Immunology, 2018
Introduction Double-blind, placebo-controlled food challenges (DBPCFCs) are the gold standard for the diagnosis of food allergy and are being used as clinical trial endpoints for new food allergy therapies. We sought to determine how these endpoints translate into meaningful data that the practicing allergist can use.
E. Sher, C. Ciaccio, N. Griffin, K. Rosen, B. Chipps   +4 more
openaire   +1 more source

Can ChatGPT provide parent education for oral immunotherapy?

Annals of Allergy, Asthma & Immunology
Oral Immunotherapy (OIT) has shown great potential for the treatment of food allergy. However, there is no global consensus on best practices for OIT. Parents of allergic children often struggle with concerns regarding OIT methodology, safety and lack of accessible educational resources.
Jana Abi-Rafeh, Diana Toscano-Rivero, Bruce D. Mazer   +2 more
openaire   +2 more sources

Reactions Among Children Undergoing Egg Oral Immunotherapy (OIT)

Journal of Allergy and Clinical Immunology, 2023
Max Laxer, Liane Beaudette, Danbing Ke, Bruce Mazer, Christine McCusker, Duncan Lejtenyi, Moshe Ben-Shoshan   +6 more
openaire   +1 more source

Impact of OIT on Cumulative Ingested Dose across Multiple Oral Immunotherapy Trials

Journal of Allergy and Clinical Immunology, 2023
Ella Parsons, Antonia Quake, Hana Seastedt, Shu Cao, Olivia Raeber, Abhinav Kaushik, Sandra Andorf, Monali Manohar, Chinthrajah Sharon, Kari Nadeau, Sayantani Sindher   +10 more
openaire   +1 more source

Safety of Peanut Oral Immunotherapy (OIT)

Journal of Allergy and Clinical Immunology, 2008
A.M. Hofmann, P. Steele, J.S. Kamilaris, S.M. Jones, K.P. Palmer, T.T. Perry, A.M. Scurlock, K.A. Althage, A.W. Burks   +8 more
openaire   +1 more source

Oral Immunotherapy (OIT) Induces Clinical Tolerance in Peanut-Allergic Children

Journal of Allergy and Clinical Immunology, 2009
P. Varshney, S.M. Jones, L. Pons, M. Kulis, P.H. Steele, A.R. Kemper, A.M. Scurlock, T.T. Perry, A.W. Burks   +8 more
openaire   +1 more source

Risk of Allergic Reactions in Children Who Attained Peanut Oral Immunotherapy (OIT) Maintenance

Journal of Allergy and Clinical Immunology, 2023
Luca Delli Colli, Benjamin Lawson, Sofianne Gabrielli, Bruce Mazer, Danbing Ke, Lydia Zhang, Duncan Lejtenyi, Chiara Lucchesi, Liane Beaudette, Julia Upton, Eyal Grunebaum, Ciro Piccirillo, Edmond Chan, Ann Clarke, Xun Zhang, Christine McCusker, Moshe Ben-Shoshan   +16 more
openaire   +1 more source

Changes In IgE and IgG4 Epitopes After Milk Oral Immunotherapy (OIT)

Journal of Allergy and Clinical Immunology, 2014
Belén de la Hoz Caballer, Cristina Vlaicu, Inmaculada Cerecedo Carballo, Mónica Rodríguez-Álvarez, Maria Carmen Diéguez Pastor, Montserrat Fernández-Rivas, Javier Martínez-Botas   +6 more
openaire   +1 more source

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Peanut Oral Immunotherapy (OIT) Modified Rush: Low Dose vs High Dose

Journal of Allergy and Clinical Immunology, 2010
P.H. Steele, J. Kamilaris, A.H. Edie, L. Pons, S.M. Jones, A.M. Scurlock, T.T. Perry, A.W. Burks   +7 more
openaire   +1 more source